Health Care/Hospital

EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress

SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...

2024-05-16 09:03 1708

Nobel Laureate Jules Hoffmann's Team Collaborates with Infinitus on Advances in Polysaccharides and Immunity

GUANGZHOU, China, May 16, 2024 /PRNewswire/ -- Recently, Professor Jean-Luc, Director of the Institute of Molecular Cell Biology at the French National Centre for Scientific Research (CNRS), Member of the Infinitus Global Scientific Advisory Board, and Principal Investigator of Hoffmann Infinitus...

2024-05-16 02:02 2621

LoRaWAN® Temperature and Humidity Sensors for Food Safety, Pharmaceutical and Beyond

XIAMEN, China, May 15, 2024 /PRNewswire/ -- In industries like pharmaceuticals, food, and logistics, maintaining the integrity of products throughout the supply chain is critical. Temperature and humidity are two key parameters that can significantly affect the quality and safety of goods, especi...

2024-05-15 23:05 1794

Momcozy Successfully Concluded Mother's Day Campaign "Momcozy Village" Supporting Motherhood

NEW YORK, May 15, 2024 /PRNewswire/ -- Reflecting on its recent Mother's Day campaign, Momcozy, a global one-stop mother and baby brand, reaffirms its commitment to supporting mothers through its "Momcozy Village

2024-05-15 22:00 1948

Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients

SUZHOU, China, May 15, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved the Investigat...

2024-05-15 20:00 1666

Center for Treatment of Paralysis and Reconstructive Nerve Surgery at Hackensack Meridian Jersey Shore University Medical Center Awarded Global Healthcare Accreditation

The Center is the first GHA accredited facility in New Jersey. MIAMI, May 15, 2024 /PRNewswire/ -- Hackensack Meridian Jersey Shore University Medical Center, located in Neptune, New Jersey, celebrates a significant milestone: the attainment of Global Healthcare Accreditation (GHA)  for Medical T...

2024-05-15 18:00 1716

Animal Quarantine Service Uncovers Foreign National Attempting to Bring Livestock Products into Japan Illegally

TOKYO, May 15, 2024 /PRNewswire/ -- Last year, the Animal Quarantine Service (AQS) uncovered a foreign national who illegally brought meat such as sausages containing pork, which are prohibited from being imported toJapan from overseas, intoTokyo International Airport, and recently there was a ca...

2024-05-15 15:00 2055

Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024

PENANG, Malaysia, May 15, 2024 /PRNewswire/ -- Island Hospital swept five awards at the GlobalHealth Asia-Pacific Awards 2024 recently. Among these are the Standout Jury Award for Hospital of the Year inAsia-Pacific and Most Sustainable Healthcare Institution of the Year inAsia-Pacific, cementing...

2024-05-15 14:45 1939

Renowned Wellness Expert Dr Jitendra Pokhriyal Returns to The Westin Resort Nusa Dua, Bali as Wellness Ambassador

BALI, Indonesia, May 15, 2024 /PRNewswire/ -- The Westin Resort Nusa Dua, Bali  is delighted to welcome backDr Jitendra Pokhriyal as their Wellness Ambassador after a four-year hiatus. Dr Jitendra, originally from the Himalayas inIndia, previously served ...

2024-05-15 10:00 2150

ESOC 2024: Higher income reduces stroke mortality risk by a third, new study shows

BASEL, Switzerland, May 15, 2024 /PRNewswire/ -- New research, presented today at the 10th European Stroke Organisation Conference (ESOC) 2024, has revealed that high-income individuals have a 32% lower risk of post-stroke mortality. Additionally, those with a higher education have a 26% lower ri...

2024-05-15 06:01 1852

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...

2024-05-15 02:52 1770

Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China

SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...

2024-05-14 21:41 2363

IMG Shares 2024 Summer Travel Trends and Top Destinations

* IMG reviewed the travel itineraries of more than 23,000 of its members with upcoming travel plans betweenJune 1st and August 31st of 2024 to determine emerging travel trends this summer. INDIANAPOLIS, May 14, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insu...

2024-05-14 21:00 1540

HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols

PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...

2024-05-14 20:00 1796

Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results

SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the '...

2024-05-14 20:00 1729

HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology

HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...

2024-05-14 20:00 1596

Pantai Hospital Kuala Lumpur Continues Legacy of Care with Community Health Screening for the Lembah Pantai Community

KUALA LUMPUR, Malaysia, May 14, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, together with Premier Integrated Labs, Pantai Integrated Rehab, and Twin Tower Medical Centre, and with support from the Breast Cancer Welfare Association Malaysia and AstraZeneca, marked a milestone in their conti...

2024-05-14 19:41 1765

Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-K

NEW YORK, May 14, 2024 /PRNewswire/ -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-K for the period endedDecember 31, 2...

2024-05-14 18:30 1699

Xinhua Silk Road: China's Tasly releases white paper, large model on TCM digital intelligence

BEIJING, May 14, 2024 /PRNewswire/ -- China's TCM product developer Tasly Pharmaceutical Group Co., Ltd. issued a white paper on digital intelligence of traditional Chinese medicine (TCM) and launched a related large model at an industrial conference onMay 9, 2024.

2024-05-14 17:07 1518

Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...

2024-05-14 11:24 2152
1 ... 88899091929394 ... 848

Week's Top Stories